Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P342. Characteristics of inflammatory bowel disease (IBD) in a cohort of patients of Gypsy ethnicity
P342. The long-term efficacy of enteral nutrition for the prevention of postoperative recurrence in Crohn's disease: a five-year prospective cohort study
Authors:

T. Yamamoto1, M. Shiraki1, S. Umegae1, K. Matsumoto1, 1Yokkaichi Social Insurance Hospital, Inflammatory Bowel Disease Centre, Yokkaichi, Japan

P342

Meta-analysis: Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use reduce colorectal cancer risk in patients with inflammatory bowel disease?

Authors:

N. Burr*, M. Hull, V. Subramanian

St. James' University Hospital, Gastroenterology, Leeds, United Kingdom

P343.

Skewed thiopurine metabolism leads to early therapeutic failure in the majority of patients with inflammatory bowel disease

Authors:

J.E. Kreijne1, M.L. Seinen1, A. Sinjewel2, G. Bouma1, C.J. Mulder1, A.A. van Bodegraven1, N.K.H. de Boer1, 1VU University Medical Centre, Gastroenterology and Hepatology, Amsterdam, Netherlands, 2VU University Medical Centre, Pharmacy department, Amsterdam, Netherlands

P343. Biochemical assay to determine thiopurine S‑methyltransferase (TPMT) activity should be used in the Jewish population, rather than genotyping
P343. Role of plasminogen activator inhibitor and thrombin activatable fibrinolysis inhibitor in the elevated thromboembolic risk seen in inflammatory bowel disease patients
P343. TPMT genotyping before thiopurine treatment results in lower leucopenia occurrence in a prospective randomized strategy study in 850 patients with inflammatory bowel disease
Authors:

M.J. Coenen1, C.J. van Marrewijk1, L. Derijks2, S.H. Vermeulen3, H. Scheffer1, B. Franke1, H.-J. Guchelaar4, D.J. de Jong5, 1Radboud University Nijmegen Medical Centre, Genetics, Nijmegen, Netherlands, 2Maxima Medical Centre, Clinical Pharmacy, Veldhoven, Netherlands, 3Radboud University Nijmegen Medical Centre, Epidemiology, Biostatistics and Health Technology, Nijmegen, Netherlands, 4Leiden University Medical Centre, Clinical Pharmacy and Toxicology, Leiden, Netherlands, 5Radboud University Nijmegen Medical Centre, Gastroenterology; Topic study group, Nijmegen, Netherlands

P343

Misconceptions about reproductive issues in female patients with inflammatory bowel disease.

Authors:

S. Chetcuti Zammit1, M. Caruana1, K.H. Katsanos2, G.J. Mantzaris3, M. Cesarini4, U. Kopylov5, L. Zammit1, P. Ellul*1

1Mater Dei Hospital, Department of Gastroenterology, Msida, Malta, 2University of Ioannina School of Medical Sciences, Department of Internal Medicine, Medical School, Ioannina, Greece, 3Evangelismos, Ophthalmiatreion Athinon and Polyclinic Hospitals, Department of Gastroenterology, Athens, Greece, 4Sapienza University of Rome, Dipartimento di Medicina Interna e Specialità' Mediche, Rome, Italy, 5Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Israel

P344.

Short and medium term efficacy of adalimumab in ulcerative colitis – a multicentre, prospective observational study

Authors:

Z. Szepes1, A. Bálint1, M. Szücs2, F. Nagy1, K. Farkas1, R. Bor1, L. Lakner3, K. Palatka4, P. Miheller5, Á. Csontos5, G. Hegede6, G. Horváth7, I. Rácz8, Á. Vincze9, P.L. Lakatos10, P.A. Golovics10, Z. Gábor7, M. Juhász5, F. Zsigmond11, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary, 3Teaching Hospital Markusovszky, Department of Gastroenterology, Szombathely, Hungary, 4University of Debrecen, 2nd Department of Medicine, Debrecen, Hungary, 5Semmelweis University, 2nd Department of Medicine, Budapest, Hungary, 6Sándor Péterfy Hospital, First Department of Medicine, Budapest, Hungary, 7Semmelweis Health Center, Department of Gastroenterology, Miskolc, Hungary, 8Petz Aladár Hospital, First Department of Medicine, Györ, Hungary, 9University of Pécs, First Department of Medicine, Pécs, Hungary, 10Semmelweis University, First Department of Medicine, Budapest, Hungary, 11National Medical Center, Department of Internal Medicine, Budapest, Hungary

P344. Common misconceptions in the management of outpatients with inflammatory bowel disease (IBD)
P344. Haemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with Immunosuppressors – increasing awareness makes diagnosis
P344. Therapeutic escalation in patients with ulcerative colitis: systematic analysis of the prevalence and risk factors in the Swiss IBD cohort
Authors:

E. Safroneeva1, S. Vavricka2, N. Fournier3, A. Straumann4, A. Schoepfer5, 1University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 2University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 3University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 4University Hospital Basel, Gastroenterology and Hepatology, Switzerland, 5University Hospital Lausanne / CHUV, Gastroenterology and Hepatology, Lausanne, Switzerland

P344

Restless-Legs-Syndrome and iron deficiency in patients with inflammatory bowel disease

Authors:

J. Becker1, F. Berger1, K. Schindelbeck2, P. Koch2, J. Preiß1, T. Karge1, B. Siegmund1, F. Marzinzik2, J. Maul*1

1Charité - University Medicine Berlin, Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology), Berlin, Germany, 2Charité - University Medicine Berlin, Campus Benjamin Franklin, Deptartment of Neurology, Berlin, Germany

P345.

Short- and long-term efficacy of granulocytapheresis in patients with active steroid-dependent ulcerative colitis refractory or intolerant to thiopurines. A retrospective single-centre study

Authors:

F.J. Fernandez-Perez, A. Moreno, F.J. Fernandez-Cano, F. Rodriguez Gonzalez, M.A. Romero Ordoñez, M. Gonzalez Barcenas, Hospital Costa del Sol, Gastroenterology, Marbella, Spain

P345. Endoscopic and clinical outcome after ileo-colic resection for Crohn's disease through laparoscopic or conventional approach
P345. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
P345. The natural history of azathioprine therapy for steroid-dependent ulcerative colitis: a Korean study
Authors:

S.K. Park1, S.K. Yang1, B.D. Ye1, K.J. Kim1, D.H. Yang1, K.W. Jung1, S.H. Park1, J.W. Kim1, J.S. Byeon1, S.J. Myung1, J.H. Kim1, 1Asan Medical Center, Gastroenterology, Seoul, South Korea

P345

Rapid weight increase in Infliximab treated Crohn's disease patients is sustained over time

Authors:

J. Lepp*, A. Forsell, U. Fyrhake, M. Lördal, S. Almer

Karolinska Institutet, Department of Medicine and GastroCentrum, Karolinska university hospital, Stockholm, Sweden

P346.

Short term dose tailoring of anti TNF-α therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response

Authors:

S. Ghaly1, S. Costello2, L. Beswick3, A. Pudipeddi4, A. Agarwal2, A. Sechi5, B. Headon3, R. Prosser6, S. Connor5, I.C. Lawrance7, M. Sparrow3, P. Bampton6, A. Walsh4, J. Andrews2, 1St. Vincent's Hospital, University of New South Wales, Department of Gastroenterology, Sydney, Australia, 2Royal Adelaide Hospital, Department of Gastroenterology, Adelaide, Australia, 3The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia, 4St. Vincent's Hospital, Department of Gastroenterology, Sydney, Australia, 5Liverpool Hospital, Department of Gastroenterology, Sydney, Australia, 6Flinders Medical Centre, Department of Gastroenterology, Adelaide, Australia, 7Fremantle Hospital, Centre for Inflammatory Bowel Disease, Fremantle, Australia

P346. Endoscopic treatment of colonic strictures in ulcerative colitis (UC): Feasibility and effectiveness